Почетна › Рак (све врсте) › Ilinois › Chicago
Kliničke studije za Рак (све врсте) u gradu Chicago, IL
Jedna studija za Рак (све врсте) traži učesnike na lokaciji u gradu Chicago ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Тражи се учесникФаза 3
- University of Illinois Chicago, Chicago
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Тражи се учесникФаза 2
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Тражи се учесникФаза 3
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- и још 1
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Тражи се учесникФаза 3
- Rush University Medical Center, Chicago
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Тражи се учесникФаза 1/2
- University of Illinois Cancer Center, Chicago
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Тражи се учесникФаза 3
- Northwestern Memorial Hospital, Chicago
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Тражи се учесникФаза 3
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Тражи се учесникФаза 2/3
- Northwestern Memorial Hospital, Chicago
- University Of Chicago Medical Center, Chicago
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Тражи се учесникФаза 2
- Lurie Children's Hospital, Chicago
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
Тражи се учесникОпсервациона студија
- Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital), Chicago
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Тражи се учесникФаза 1
- University of Chicago Medical Center /ID# 278863, Chicago
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Тражи се учесникФаза 1
- Northwestern University ( Site 0101), Chicago
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Тражи се учесникФаза 2
- University of Chicago Medical Center /ID# 274742, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Тражи се учесникФаза 1/2
- Northwestern Memorial Hospital, Chicago
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Тражи се учесникОпсервациона студија
- Northwestern University, Chicago
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Тражи се учесникФаза 3
- Investigative Site, Chicago
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Тражи се учесникФаза 3
- University of Chicago Medical Center /ID# 280149, Chicago
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Тражи се учесникФаза 2
- Cancer Treatment Centers of America-Chicago, Chicago
Evaluating the Communication Between Patients and Providers in Cancer Clinics
Тражи се учесник
- Northwestern Memorial Hospital, Chicago
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Тражи се учесник
- Advocate Illinois Masonic Medical Center, Chicago
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Тражи се учесникФаза 1
- University of Chicago, Chicago
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Тражи се учесникОпсервациона студија
- Northwestern University Feinberg School of Medicine, Chicago
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
Тражи се учесникОпсервациона студија
- Ann &Robert H Lurie Children's Hospital, Chicago
Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Тражи се учесникОпсервациона студија
- Ann & Robert H Lurie Childrens Hospital, Chicago
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Тражи се учесникФаза 3
- Insight Research Institute, Chicago
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Тражи се учесникФаза 3
- Northwestern University, Chicago
Project: Every Child for Younger Patients With Cancer
Тражи се учесникОпсервациона студија
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- University of Illinois, Chicago
- и још 1
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Тражи се учесникФаза 3
- University of Chicago, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Тражи се учесникФаза 1/2
- University of Chicago Medical Center, Chicago
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Тражи се учесникФаза 1/2
- Site 05, Chicago
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Tempus AI, Chicago
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Тражи се учесникФаза 2
- Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
International Rare Brain Tumor Registry
Тражи се учесникОпсервациона студија
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- The University of Chicago Medicine, Chicago
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Тражи се учесник
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Molecular Genetics Studies of Cancer Patients and Their Relatives
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- John H Stroger Jr Hospital of Cook County, Chicago
- Rush University Medical Center, Chicago
Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program
Тражи се учесникЗдраве особе су добродошле
- Northwestern University, Chicago
Childhood Cancer Survivor Study
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Ana & Robert H. Lurie Children's Hospital of Chicago, Chicago
- University of Chicago, Chicago
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
Тражи се учесникФаза 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Тражи се учесникФаза 1/2
- Northwestern Memorial Hospital, Chicago
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Тражи се учесникОпсервациона студија
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life
Тражи се учесник
- Northwestern University, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Тражи се учесникФаза 1/2
- University of Chicago, Chicago
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Тражи се учесникФаза 1/2
- University of Chicago Medical Center, Chicago
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Тражи се учесникФаза 2
- University of Chicago, Chicago
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Тражи се учесник
- University of Chicago Medicine, Chicago
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Тражи се учесникФаза 1/2
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Chicago
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Тражи се учесникФаза 1
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
Тражи се учесникФаза 1
- University of Chicago, Chicago
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Тражи се учесник
- Advocate Illinois Masonic Medical Center, Chicago
Studije za Рак (све врсте) u drugim gradovima
- Houston, TX124 студија
- New York City, NY105 студија
- Boston, MA90 студија
- Los Angeles, CA73 студија
- Nashville, TN65 студија
- Durham, NC61 студија
- Washington, DC60 студија
- Philadelphia, PA57 студија
- Arlington, VA52 студија
- St. Louis, MO51 студија
- Atlanta, GA49 студија
- Seattle, WA48 студија
Ostale studije u gradu Chicago
- Рак дојке59 студија
- Немалоклетни карцином плућа59 студија
- Рак простате45 студија
- Рак плућа43 студија
- Метастатски карцином42 студија
- Гојазност40 студија
- Рак јајника36 студија
- Колоректални карцином32 студија
- Шлог31 студија
- Плоскоклеточни карцином главе и врата29 студија
- Гојазност29 студија
- Затајење срца28 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.